Delivery Order SPE2DB20D3101-SPE2DB24FRAF4

Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,479.78 Firm Fixed Price delivery order is for the supply of 4,565,481,718 units of the prescription medication Febuxostat 40 mg tablets. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,119,086 units of Febuxostat 40 mg tablets. The $2,347.52 firm fixed-price contract has an ultimate completion date of August 17, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the delivery of 40 milligram febuxostat tablets in 30-count packages, with a potential value of $1,423.80 and a completion date of February 2, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,563.56, is for the delivery of the medication febuxostat 40 mg tablets. The contract has a final completion date of May 8, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Febuxostat 40 mg tablets. The $2,437.82 firm fixed-price contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide febuxostat 40 mg tablets. The $1,000.34 award has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor to the DLA, providing a range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract, valued at $1,014.19, is for the supply of 4565560153 FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price pricing structure and an ultimate completion date of August 26, 2024. There is no set-aside designation on this contract. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.14 firm fixed-price delivery order is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,290.59 firm-fixed price delivery order contract is for the supply of febuxostat 40 mg tablets. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRAF4
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,563,472,907 units of febuxostat 40 mg tablets, with a potential value of $1,659.19. The delivery order has a completion date of January 30, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken, Pennsylvania to support military treatment programs and facilities. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024. Additionally, the company is the prime contractor on a separate indefinite delivery contract awarded by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 4/29/24, 9:58 AM